Guotai Guomian Showcases End-to-End Pharma Solutions at CPhI China 2025

Emerging Market Focus with API+Compliance+Supply Chain Integration

Shanghai, China – July 1, 2025– Jiangsu Guotai Guomian Trading Co., Ltd., a leading global provider of integrated pharmaceutical supply chain solutions, successfully exhibited at CPhI China 2025 (June 24-26), Asia's premier pharmaceutical sourcing event attracting 15,000+ overseas visitors from 166 countries at Shanghai New International Expo Centre.

Strategic Positioning for Emerging Markets

As an emerging markets specialist with 30 years’ expertise, Guotai Guomian demonstrated its full-spectrum capabilities:

✅ Core Product Portfolio: APIs, Intermediates & Specialty Chemicals
✅ Compliance-First Approach: Regulatory support for fast-evolving markets
✅ Supply Chain Optimization: Customized logistics and production demand solutions for India, LATAM, Africa, SEA & Eastern Europe

On-Ground Engagement Highlights

The customized booth facilitated 180+ professional engagements, with significant traction from:

• India: Top 20 generic drug makers exploring specialty APIs’ intermediates & chemicals
• LATAM: Negotiations on cardiovascular and anti-infective APIs supply
  
• Southeast Asia: Pharmaceutical producers seeking raw materials & packaging with production solutions
  
• Eastern Europe: New products BD & technical dialogues on GMP documentation

"CPhI reaffirms our vision as the preferred partner for emerging markets," stated, G.M., William Lee, "Our 'One-Stop raw materials + Compliance + Logistics' model eliminates cross-border pain points – from Brazil’s ANVISA filings to India’s custom clearance challenges."

Tangible Business Outcomes

The event accelerated:

🔹 6 strategic partnerships with Indian & Africa pharma companies
🔹 3 new projects in antiviral & oncology intermediates and excipients
🔹 Regulatory pathway agreements for African & Eastern Europe markets entry

Commitment to Sustainable Growth

Building on CPhI momentum, Guotai Guomian will:

• Accelerate development of 4+ market-driven APIs and specialty chemicals
  
• Enhance technical consulting team providing suitable synthesis technology, process optimization & other technical support services for CDMO projects (Q4 2025)
  
• Expand market presence across Africa and Southeast Asia

"Through continuous innovation in compliance-integrated supply chains, Guotai Guomian remains committed to Making Healthcare More Valuable across global emerging markets."